Modulation of Murine Macrophage Nitric Oxide Synthesis by Liposomal Phospholipids: Correlation with Liposome Immune Adjuvant Activity

References

• Abbas A. K., Urioste S., Collins T. L., Boom W. H. Heterogeneity of helper/inducer T lymphocytes. IV. Stimulation of resting and activated B cells by Thl and Th2 clones. J. Immunol. (1990); 144: 2031–2037
   PubMed Web of Science ®Google Scholar
• Alving C. R. Immunologic aspects of liposomes: Presentation and processing of liposomal protein and phospholipid antigens. Biochim. Biophys. Acta Rev. Biomembr. (1992); 1113: 307–322
   PubMed Web of Science ®Google Scholar
• Bakouche Q., David F., Gerlier D. Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoylphosphatidylethanolamine linked to the secretion of prostaglandins by macrophages. Eur. J Immunol. (1987); 17: 1839–1842
   PubMed Web of Science ®Google Scholar
• Barratt G. M., Raddassi K., Petit J. F., Tenu J. P. MDP and LPS act synergistically to induce arginine-dependent cytostatic activity in rat alveolar macrophages. Int. J. Immunopharmacol. (1991); 13: 159–165
   PubMed Web of Science ®Google Scholar
• Bazzi M. D., Youakim M. A., Nelsestuen G. L. Importance of phosphatidylethanolamine for association of protein kinase C and other cytoplasmic proteins with membranes. Biochemistry (1992); 31: 1125–1134
   PubMed Web of Science ®Google Scholar
• Bromander A., Holmgren J., Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. Cell. Immunol. (1991); 146: 2908–2914
   Google Scholar
• Bui T., Dykers T., Hu S.-L., Faltynek C. R., Ho R. J.Y. effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. JAIDS (1994); 7: 799–806
   Google Scholar
• Caselli E., Baricordi O. R., Melchiorri L., Bellini F., Ponzin D., Bruni A. Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserines containing unsaturated acyl chains. Immunopharmacology (1992); 23: 205–213
   PubMed Web of Science ®Google Scholar
• Caselli E., Bellini F., Ponzin D., Baricordi O. R., Bruni A. Role of protein kinase c in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells. Immunopharmacology (1992); 24: 191–201
   PubMedGoogle Scholar
• Coutelier J. P., Van Der Logt J. T., Heessen F. W., Vink A., Van Snick J. Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med. (1988); 168: 2373–2378
   PubMed Web of Science ®Google Scholar
• Cunha F. Q., Moncada S., Liew F. Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem. Biophys. Res. Commun. (1992); 182: 1155–1159
   PubMed Web of Science ®Google Scholar
• Deng W., Thiel B., Tannenbaum C. S., Hamilton T. A., Stuehr D. J. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. (1993); 151: 322–329
   PubMed Web of Science ®Google Scholar
• Drapier J. C., Wietzerbin J., Hibbs J. B., Jr. Interferongamma and tumor necrosis factor induce the L-argininedependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. (1988); 18: 1587–1592
   PubMed Web of Science ®Google Scholar
• Duits A. J., Van Puijenbroek A., Vermeulen H., Hofhuis F. M.A., Van De Winkel J. G.J., Capel P. J.A. Immunoadjuvant activity of a liposomal IL-6 formulation. Vaccine (1993); 11: 777–781
   PubMed Web of Science ®Google Scholar
• Fidler I. J., Sone S., Fogler W. E., Smith D., Braun D. G., Tarcsay L., Gisler R. H., Shroit A. J. Efficacy of liposomes containing a lipophilic derivative of muramyl tripeptide for activating the tumoricidal properties of alveolar macrophages in vivo. J. Biol. Resp. Modif. (1982); 1: 43–55
   Google Scholar
• Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Jr., Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol (1990); 8: 303–333
   PubMed Web of Science ®Google Scholar
• Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. (1989); 170: 2081–2095
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Fitch F. W. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol (1988); 140: 4245–4252
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Pinnas M., Wong T., Fitch F. W. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol (1991); 146: 1750–1758
   PubMed Web of Science ®Google Scholar
• Garnier F., Forquet F., Bertolino P., Gerlier D. Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: Effect of the phospholipid composition. Vaccine (1991); 9: 340–345
   PubMed Web of Science ®Google Scholar
• Girolomoni G., Pastore S., Zacchi V., Cavani A., Marconi A., Giannetti A. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity. J. Immunol (1993); 150: 4236–4243
   PubMed Web of Science ®Google Scholar
• Gregoriadis G., Davis D., Davies A. Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine (1987); 5: 145–151
   PubMed Web of Science ®Google Scholar
• Harding C. V., Collins D. S., Kanagawa O., Unanue E. R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol (1991); 147: 2860–2863
   PubMed Web of Science ®Google Scholar
• Ianaro A., O'Donnell C. A., Di Rosa M., Liew F. Y. A nitric oxide synthase inhibitor reduces inflammation, downregulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994); 82: 370–375
   PubMed Web of Science ®Google Scholar
• Kelso A., Macdonald H. R., Smith K. A., Cerottini J.-C., Brunner K. T. Interleukin-2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. J. Immunol (1984); 132: 2932–2938
   PubMed Web of Science ®Google Scholar
• Kipps T. J., Parham P., Punt J., Herzenberg L. A. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. (1985); 161: 1–17
   PubMed Web of Science ®Google Scholar
• Kleinerman E. S., Raymond A. K., Bucana C. D., Jaffe N., Harris M. B., Krakoff I. H., Benjamin R., Fidler I. J. Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid). Cancer Immunol. Immunother. (1992); 34: 211–220
   PubMed Web of Science ®Google Scholar
• Kochs G., Hummel R., Fiebich B., Sarre T. F., Marme D., Hug H. Activation of purified human protein kinase c alpha and beta I isoenzymes in vitro by Ca2+, phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate. Biochem. J. (1993); 291: 627–633
   PubMed Web of Science ®Google Scholar
• Langrehr J. M., Hoffman R. A., Lancaster J. R., Jr., Simmons R. L. Nitric oxide-a new endogenous immunomodulator. Transplantation (1993); 55: 1205–1212
   PubMed Web of Science ®Google Scholar
• Liew F. Y., Li Y., Severn A., Millott S., Schmidt J., Salter M., Moncada S. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Thl cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol (1991); 21: 2489–2494
   PubMed Web of Science ®Google Scholar
• Manca F., Fenoglio D., Li Pira G., Kunkl A., Celada F. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. (1991); 173: 37–48
   PubMed Web of Science ®Google Scholar
• Manetti R., Barak V., Piccinni M.-P., Sampognaro S., Parronchi P., Maggi E., Dinarello C. A., Romagnani S. Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Res. Immunol (1994); 145: 93–100
   Web of Science ®Google Scholar
• Mannhalter J. W., Neychev H. O., Zlabinger G. J., Ahmad R., Eibl M. M. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin. exp. Immunol (1985); 61: 143–151
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz J., Chain B. M. Differential regulation of cytokine production by nitric oxide. Immunology (1993); 80: 146–159
   PubMed Web of Science ®Google Scholar
• Miyajima H., Hirano T., Hirose S., Karasuyama H., Okumura K., Ovary Z. Suppression by IL-2 of IgE production by B cells stimulated by IL-4. J. Immunol (1991); 146: 457–162
   PubMed Web of Science ®Google Scholar
• Monastra G., Bruni A. Decreased serum level of tumor necrosis factor in animals treated with lipopolysaccharide and liposomes containing phosphatidylserine. Lymph. Cytokine Res. (1992); 11: 39–43
   PubMedGoogle Scholar
• Moncada S., Palmer R. M.J., Higgs E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991); 43: 109–142
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Coffman R. L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol (1989); 7: 145–173
   PubMed Web of Science ®Google Scholar
• Orr J. W., Newton A. C. interaction of protein kinase c with phosphatidylserine. 1. Cooperativity in lipid binding. Biochemistry (1992); 31: 4661–1667
   PubMed Web of Science ®Google Scholar
• Pelassy C., Aussel C., Fehlmann M. Phospholipid metabolism and T cell activation: receptor triggering is associated with the inhibition of phosphatidylserine synthesis. Cell. Signal (1989); 1: 99–105
   PubMed Web of Science ®Google Scholar
• Phillips N. C., Emili A. Immunogenicity of immunoliposomes. Letters in Immunology (1991); 30: 291–296
   PubMed Web of Science ®Google Scholar
• Phillips N. C. Impaired stimulation of anti-bovine serum albumin IgG antibodies by vaccine adjuvants in murine acquired immunodeficiency syndrome. FEMS Microbiol Immunol (1992a); 89: 209–218
   Google Scholar
• Phillips N. C. Liposomal carriers for the treatment of acquired immune deficiency syndromes. Bull. Inst. Pasteur (1992b); 90: 205–230
   Google Scholar
• Phillips N. C., Emili A. Enhanced antibody response to liposome-associated proteins: preferential stimulation of IgG2a/IgG2b production. Vaccine (1992); 10: 151–158
   PubMed Web of Science ®Google Scholar
• Phillips N. C., Loutfi A., A-Kareem A. M., Shibata H. R., Baines M. G. Clinical evaluation of liposomal tumor antigen vaccines in patients with stage-III melanoma. Cancer Detect. Prevent. (1990); 14: 491–496
   PubMedGoogle Scholar
• Phillips N. C., Moras M. L., Chedid L., Lefrancier P., Bernard J. M. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide. Cancer Res. (1985); 45: 128–134
   PubMed Web of Science ®Google Scholar
• Phillips N. C., Rioux J. D., Tsao M-S. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide. Hepatology (1988); 8: 1046–1050
   PubMed Web of Science ®Google Scholar
• Quill H., Carlson L., Fox B. S., Weinstein J. N., Schwartz R. H. Optimization of antigen presentation to T cell hybridomas by purified la molecules in planar membranes. J. Immunol. Methods (1987); 98: 29–41
   PubMed Web of Science ®Google Scholar
• Roof R. W., Luescher I. F., Unanue E. R. Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc. Natl. Acad. Sci. USA (1990); 87: 1735–1739
   PubMed Web of Science ®Google Scholar
• Shahum E., ThÉRien H-M. Immunopotentiation of the humoral response by liposomes:encapsulation versus linkage. Immunology (1988); 65: 315–317
   PubMed Web of Science ®Google Scholar
• Storm G., Oussoren C., Peeters P. A.M., Barenholz Y. Tolerability of liposomes in vivo. Liposome Technology, Volume III, G. Gregoriadis. CRC Press, Boca Raton, Florida (1993); 345–383
   Google Scholar
• Tan L., Gregoriadis G. Effect of interleukin-2 on the immunoadjuvant action of liposomes. Biochem. Soc. Trans. (1989); 17: 693–694
   Web of Science ®Google Scholar
• Tzehoval E., Sztein M. B., Goldstein A. L. Thymosins α1, and β4 potentiate the antigen-presenting capacity of macrophages. Immunopharmacology (1989); 18: 107–113
   PubMed Web of Science ®Google Scholar
• Ullrich S. E., Fidler I. J. Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens. J. Leukocyte Biol. (1992); 52: 489–494
   PubMed Web of Science ®Google Scholar
• Van Rooijen N., Van Nieuwmegen R. Use of liposomes as biodegradable and harmless adjuvants. Meth. Enzymol. (1983); 93: 83–95
   PubMed Web of Science ®Google Scholar
• Vingerhoets J., Vanham G., Kestens L., Penne G., Leroux-Roels G., Gigase P. Deficient T-cell responses in nonresponders to hepatitis B vaccination: absence of TH1 cytokine production. Immunol. Letts. (1994); 39: 163–168
   PubMed Web of Science ®Google Scholar
• Williams M. E., Chang T. L., Burke S. K., Litchman A. H., Abbas A. K. Activation of functionally distinct subsets of CD4+ lymphocytes. Immunol. Res. (1991); 142: 23–28
   Google Scholar